Biomarkers for Radiation Biodosimetry and Correlation with Hematopoietic Injury in a Humanized Mouse Model.

Autor:	Wang Q; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Bacon BA; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Taveras M; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Phillippi MA; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Wu X; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Broustas CG; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Shuryak I; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032., Turner HC; Center for Radiological Research, Columbia University Irving Medical Center, New York, New York 10032.
Jazyk:	angličtina
Zdroj:	Radiation research [Radiat Res] 2024 Sep 01; Vol. 202 (3), pp. 541-551.
DOI:	10.1667/RADE-24-00049.1
Abstrakt:	After a large-scale radiological or nuclear event, hundreds of thousands of people may be exposed to ionizing radiation and require subsequent medical management. Acute exposure to moderate doses (2-6 Gy) of radiation can lead to the hematopoietic acute radiation syndrome, in which the bone marrow (BM) is severely compromised, and severe hemorrhage and infection are common. Previously, we have developed a panel of intracellular protein markers (FDXR, ACTN1, DDB2, BAX, p53 and TSPYL2), designed to reconstruct absorbed radiation dose from human peripheral blood (PB) leukocyte samples in humanized mice up to 3 days after exposure. The objective of this work was to continue to use the humanized mouse model to evaluate biomarker dose-/time- kinetics in human PB leukocytes in vivo, at an earlier (day 2) and later (day 7) time point, after exposure to total-body irradiation (TBI) doses of 0 to 2 Gy of X rays. In addition, to assess hematological sensitivity and radiation-induced injury, PB leukocyte cell counts, human BM hematopoietic stem cell (HSC) and progenitor cell [multipotent progenitor (MPP), common myeloid progenitor (CMP), granulocyte myeloid progenitor (GMP), megakaryocyte/erythrocyte progenitor (MEP) and multi-lymphoid progenitor (MLP)] levels were measured, and their correlation was also examined as the BM damages are difficult to assess by routine tests. Peripheral blood B-cells were significantly lower after TBI doses of 0.5 Gy on day 2 and 2 Gy on days 2 and 7; T-cells were significantly reduced only on day 2 after 2 Gy TBI. Bone marrow HSCs and MPP cells showed a dose-dependent depletion after irradiation with 0.5 Gy and 2 Gy on day 2, and after 1 Gy and 2 Gy on day 7. Circulating B cells correlated with HSCs, MPP and MLP cells on day 2, whereas T cells correlated with MPP, and myeloid cells correlated with MLP cells. On day 7, B cells correlated with MPP, CMP, GMP and MEP, while myeloid cells correlated with CMP, GMP and MEP. The intracellular leukocyte biomarkers were able to discriminate unirradiated and irradiated samples at different time points calculated by receiver operating characteristic (ROC) curve. Using machine learning algorithm methods, combining ACTN1, p53, TSPYL2 and PB-T cell and PB-B cell counts served as a strong predictor (area under the ROC >0.8) to distinguish unirradiated and irradiated samples independent of the days after TBI. The results further validated our biomarker-based triage assay and additionally evaluated the radiation sensitivity of the hematopoietic system after TBI exposures. (© 2024 by Radiation Research Society. All rights of reproduction in any form reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu